My Speaker List

After the Nobel, What Next for CRISPR Gene-editing Therapies?

CRISPR has transformed the possibilities for curing diseases caused by one or several genetic mutations. Clinical trials for therapies that utilize the genome editing technology are already underway for debilitating conditions such as sickle-cell anemia, delivering treatments in disease areas where none currently exist.

Read the original article in The Guardian.